DK407488A - Fremgangsmaade til behandling af overskud af jern - Google Patents

Fremgangsmaade til behandling af overskud af jern

Info

Publication number: DK407488A
Authority: DK; Denmark
Prior art keywords: iron; profits; treating; procedure; mammal
Prior art date: 1986-11-21

Application number

DK407488A

Other languages

English (en)

Other versions

DK167650B1 (da

DK407488D0 (da

Inventor

John W Adamson

Joseph W Eschbach

Michael R Downing

Joan C Egrie

Original Assignee

Kirin Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-21

Filing date

1988-07-21

Publication date

1988-07-21

1988-07-21 Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc

1988-07-21 Publication of DK407488D0 publication Critical patent/DK407488D0/da

1988-07-21 Publication of DK407488A publication Critical patent/DK407488A/da

1993-12-06 Application granted granted Critical

1993-12-06 Publication of DK167650B1 publication Critical patent/DK167650B1/da

Links

XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 8
229910052742 iron Inorganic materials 0.000 title abstract 4
241000124008 Mammalia Species 0.000 abstract 3
210000003743 erythrocyte Anatomy 0.000 abstract 2
102000003951 Erythropoietin Human genes 0.000 abstract 1
108090000394 Erythropoietin Proteins 0.000 abstract 1
229940105423 erythropoietin Drugs 0.000 abstract 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Treatment Of Water By Oxidation Or Reduction (AREA)
Manufacture Of Iron (AREA)
Chemical Treatment Of Metals (AREA)
Treatment Of Water By Ion Exchange (AREA)
Compounds Of Iron (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Hydrogen, Water And Hydrids (AREA)

DK407488A 1986-11-21 1988-07-21 Anvendelse af erythropoietin til fremstilling af et laegemiddel mod jernoverskudsrelaterende lidelser DK167650B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US93349586		1986-11-21
US06/933,495 US5013718A (en)	1986-11-21	1986-11-21	Method for treating iron overload using EPO
PCT/US1987/002673 WO1988003808A1 (en)	1986-11-21	1987-10-19	Method for treating iron overload
US8702673		1987-10-19

Publications (3)

Publication Number	Publication Date
DK407488D0 DK407488D0 (da)	1988-07-21
DK407488A true DK407488A (da)	1988-07-21
DK167650B1 DK167650B1 (da)	1993-12-06

Family

ID=25464076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK407488A DK167650B1 (da)	1986-11-21	1988-07-21	Anvendelse af erythropoietin til fremstilling af et laegemiddel mod jernoverskudsrelaterende lidelser

Country Status (16)

Country	Link
US (1)	US5013718A (da)
EP (1)	EP0269394B1 (da)
JP (1)	JPH0692316B2 (da)
KR (1)	KR950009100B1 (da)
AT (1)	ATE68352T1 (da)
AU (1)	AU602028B2 (da)
CA (1)	CA1322165C (da)
DE (1)	DE3773852D1 (da)
DK (1)	DK167650B1 (da)
ES (1)	ES2039252T3 (da)
GR (1)	GR3003254T3 (da)
IE (1)	IE60865B1 (da)
IL (1)	IL84275A (da)
NZ (1)	NZ222432A (da)
PT (1)	PT86187B (da)
WO (1)	WO1988003808A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2858752B2 (ja) *	1987-04-10	1999-02-17	オーソ・フアーマシユーチカル・コーポレーシヨン	正常な哺乳動物のヘマトクリツト値の増大方法
US5766897A (en) *	1990-06-21	1998-06-16	Incyte Pharmaceuticals, Inc.	Cysteine-pegylated proteins
US6012450A (en) *	1993-01-29	2000-01-11	Aradigm Corporation	Intrapulmonary delivery of hematopoietic drug
US5354934A (en) *	1993-02-04	1994-10-11	Amgen Inc.	Pulmonary administration of erythropoietin
EP0784480B1 (en)	1994-11-03	2003-10-15	Boehringer Mannheim Gmbh	Use of erythropoietin in the treatment of rheumatoid arthritis
CA2216443A1 (en)	1995-03-31	1996-10-03	Aradigm Corporation	Intrapulmonary delivery of hematopoietic drug
TW586933B (en) *	1996-06-20	2004-05-11	Chugai Pharmaceutical Co Ltd	Compositions for treating liver-complaints using EPO
US5952226A (en) *	1996-11-05	1999-09-14	Modex Therapeutiques	Hypoxia responsive EPO producing cells
AR019025A1 (es)	1998-04-09	2001-12-26	Roche Diagnostics Gmbh	Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado
EP0965349A1 (de) *	1998-06-18	1999-12-22	Roche Diagnostics GmbH	Verwendung von Erythropoietin zur Behandlung von Hämochromatosen
US6210924B1 (en)	1998-08-11	2001-04-03	Amgen Inc.	Overexpressing cyclin D 1 in a eukaryotic cell line
DE19857609A1 (de) *	1998-12-14	2000-06-15	Hannelore Ehrenreich	Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
WO2001035095A2 (en) *	1999-11-12	2001-05-17	Rothenberg Barry E	Diagnostic test for hemochromatosis
US7160855B2 (en) *	2002-03-14	2007-01-09	Children's Hospital & Research Center At Oakland	Enhancement of iron chelation therapy
DE10234192B4 (de)	2002-07-26	2009-11-26	Epoplus Gmbh Co.Kg	Verwendung von Erythropoetin
WO2004022593A2 (en) *	2002-09-09	2004-03-18	Nautilus Biotech	Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
WO2008065372A2 (en)	2006-11-28	2008-06-05	Nautilus Biotech, S.A.	Modified erythropoietin polypeptides and uses thereof for treatment
WO2012174157A1 (en)	2011-06-13	2012-12-20	Cedars-Sinai Medical Center	Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
US10694962B2 (en)	2011-06-13	2020-06-30	Cedars-Sinai Medical Center	Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
FR3037592B1 (fr)	2015-06-18	2017-06-09	Michelin & Cie	Pneumatique pourvu d'une bande de roulement comprenant un elastomere dienique et un systeme d'elastomeres thermoplastiques
EP4674480A3 (en)	2020-10-02	2026-04-08	Keros Therapeutics, Inc.	Methods of using activin receptor type ii variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0686480B2 (ja) *	1983-02-21	1994-11-02	雪印乳業株式会社	エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) *	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) *	1983-12-13	1987-10-27	Kiren-Amgen, Inc.	DNA sequences encoding erythropoietin
US4667016A (en) *	1985-06-20	1987-05-19	Kirin-Amgen, Inc.	Erythropoietin purification

1986
- 1986-11-21 US US06/933,495 patent/US5013718A/en not_active Expired - Lifetime
1987
- 1987-10-19 AU AU81794/87A patent/AU602028B2/en not_active Expired
- 1987-10-19 KR KR1019880700864A patent/KR950009100B1/ko not_active Expired - Lifetime
- 1987-10-19 WO PCT/US1987/002673 patent/WO1988003808A1/en not_active Ceased
- 1987-10-25 IL IL84275A patent/IL84275A/xx not_active IP Right Cessation
- 1987-11-03 NZ NZ222432A patent/NZ222432A/xx unknown
- 1987-11-18 IE IE311387A patent/IE60865B1/en not_active IP Right Cessation
- 1987-11-18 CA CA000552139A patent/CA1322165C/en not_active Expired - Lifetime
- 1987-11-19 JP JP62293071A patent/JPH0692316B2/ja not_active Expired - Lifetime
- 1987-11-20 PT PT86187A patent/PT86187B/pt active IP Right Revival
- 1987-11-20 DE DE8787310300T patent/DE3773852D1/de not_active Expired - Lifetime
- 1987-11-20 ES ES198787310300T patent/ES2039252T3/es not_active Expired - Lifetime
- 1987-11-20 AT AT87310300T patent/ATE68352T1/de not_active IP Right Cessation
- 1987-11-20 EP EP87310300A patent/EP0269394B1/en not_active Expired - Lifetime
1988
- 1988-07-21 DK DK407488A patent/DK167650B1/da not_active IP Right Cessation
1991
- 1991-12-02 GR GR91401882T patent/GR3003254T3/el unknown

Also Published As

Publication number	Publication date
EP0269394B1 (en)	1991-10-16
ATE68352T1 (de)	1991-11-15
JPH0692316B2 (ja)	1994-11-16
DK167650B1 (da)	1993-12-06
JPS63159322A (ja)	1988-07-02
DK407488D0 (da)	1988-07-21
AU602028B2 (en)	1990-09-27
PT86187B (pt)	1990-11-07
IL84275A (en)	1993-04-04
WO1988003808A1 (en)	1988-06-02
DE3773852D1 (de)	1991-11-21
US5013718A (en)	1991-05-07
ES2039252T3 (es)	1993-09-16
CA1322165C (en)	1993-09-14
IE60865B1 (en)	1994-08-24
GR3003254T3 (en)	1993-02-17
IE873113L (en)	1988-05-21
KR890700032A (ko)	1989-03-02
NZ222432A (en)	1990-07-26
AU8179487A (en)	1988-06-16
KR950009100B1 (ko)	1995-08-14
EP0269394A2 (en)	1988-06-01
EP0269394A3 (en)	1988-09-14
PT86187A (en)	1987-12-01

Similar Documents

Publication	Publication Date	Title
DK407488D0 (da)	1988-07-21	Fremgangsmaade til behandling af overskud af jern
BG44538A3 (bg)	1988-12-15	Метод за получаване на соли на 5-метокси-2-голяма скоба(4 метокси- 3,5-диметил-2-пиридинил)-метил сулфонил голяма скоба-1н-бензимидазол
DK153385D0 (da)	1985-04-03	Monoklonale antistoffer, hybridoma-cellelinier samt fremgangsmaade til fremstilling af monoklonale antistoffer
ATE190496T1 (de)	2000-04-15	Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
DK442788A (da)	1988-10-07	Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
ATE22657T1 (de)	1986-10-15	Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung.
FR2311818A1 (fr)	1976-12-17	Composition et procede pour le traitement de fibres keratiniques
EP0179390A3 (de)	1987-07-29	L-Lysin- und L-Histidinpyruvat
DZ701A1 (fr)	2004-09-13	Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
ATE7138T1 (de)	1984-05-15	Verfahren zur herstellung von 1,5-didesoxy-1,5imino-d-glucitol und dessen n-derivaten.
DE3777097D1 (de)	1992-04-09	Herstellungsverfahren von tert.-butylmethacrylat.
PT87197A (pt)	1988-05-01	Processo para preparacao de agentes terapeuticos eritropoietina
SE7608174L (sv)	1977-01-19	Forfarande for framstellning av antiserum
DK556984D0 (da)	1984-11-23	Apparat til forebyggelse og behandling af svulster, caries og andre lidelser med vaesentlig reduktion af smerter ved hjaelp af elektriskeog/eller magnetiske impulser
OA07002A (fr)	1983-08-31	Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale.
ES522223A0 (es)	1984-08-16	Un procedimiento para la preparacion de 2-cuanidino-4-imidazoliltiazoles.
FR2529083B2 (fr)	1987-04-30	Appareil pour la retroperfusion sanguine, destine notamment au traitement d'infarctus par injection de sang arteriel dans le sinus coronaire
DK0739354T3 (da)	1999-11-01	Præparater og fremgangsmåder, hvor der anvendes ikke-bundet MPL-receptor til stimulering af blodpladeproduktion
DK0752884T3 (da)	2004-11-22	Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner
EP0345260A4 (en)	1990-05-14	METHOD FOR TREATING MAMMALS USING EARLY PREGNANCY FACTOR (EPF) ANTIBODIES.
NO874694D0 (no)	1987-11-11	Begrenset inngangsmetode for samtidig indusering av flere frakturer i avviksbroenner.
IT1201210B (it)	1989-01-27	Metodo rapido di prova per determinare la sedimentazione del sangue venoso
SE7409081L (sv)	1975-01-13	Barbitursyraderivat.
SU1405143A1 (ru)	1996-05-10	Способ лечения острых нарушений мозгового кровообращения
EP0070167A3 (en)	1983-09-07	Hypertension treatment

Legal Events

Date	Code	Title	Description
1993-12-06	B1	Patent granted (law 1993)
2007-11-05	PUP	Patent expired